Guilford seeks partners throughout the world for a number of our technologies. The preferred partnering strategy may vary depending on the compound, target indication(s), stage of development and geographic markets. Below is a description of Guilford technologies we are interested in partnering, particularly in the areas indicated.
The information included in the Licensing section of this website is intended solely for initiating partnering discussions with potential development and commercialization collaborators. This information is not intended as prescribing or promotional information and includes forward-looking statements. Physicians or patients looking for prescribing information are referred to our marketed products section. Potential investors are referenced to and reminded that such forward looking statements involve risks and uncertainties, including those described in the section entitled "Risk Factors" from the Company's Quarterly Report on Form 10-Q, filed May 10, 2004, and other filings of the Company with the Securities and Exchange Commission.
This page was last updated on
Copyright© 2001 Guilford Pharmaceuticals Inc.